Showing 801 - 820 results of 3,434 for search 'Eyemo~', query time: 2.77s Refine Results
  1. 801
  2. 802
  3. 803
  4. 804
  5. 805
  6. 806
  7. 807
  8. 808
  9. 809
  10. 810
  11. 811
  12. 812
  13. 813
  14. 814
  15. 815

    Study protocol for Adaptive ChemoTherapy for Ovarian cancer (ACTOv): a multicentre phase II randomised controlled trial to evaluate the efficacy of adaptive therapy (AT) with carboplatin, based on changes in CA125, in patients with relapsed platinum-sensitive high-grade serous or high-grade endometrioid ovarian cancer by Michelle Lockley, Kathy Robinson, Rowan Miller, Charlie Gourley, Nicholas Counsell, Iain Mcneish, Trevor Graham, Uma Anne Mukherjee, Helen Hockings, Apini Patel, Priya Narayanan, Katie Wilkinson, Harjot Dhanda, Alexander R A Anderson

    Published 2024-12-01
    “…Introduction Adaptive ChemoTherapy for Ovarian cancer (ACTOv) is a phase II, multicentre, randomised controlled trial, evaluating an adaptive therapy (AT) regimen with carboplatin in women with relapsed, platinum-sensitive high-grade serous or high-grade endometrioid cancer of the ovary, fallopian tube and peritoneum whose disease has progressed at least 6 months after day 1 of the last cycle of platinum-based chemotherapy. …”
    Get full text
    Article
  16. 816
  17. 817

    Quantitative evaluation of the wide-field fundus photographs in eyes with severe stage 3 and stage 4A retinopathy of prematurity by Sadik Etka Bayramoglu, Nihat Sayin, Gurkan Erdogan

    Published 2025-01-01
    “…Results In the severe Stage 3 group, dense fibrous membranes, vertical tractional bands, and dragging were detected in 18 eyes (55%), in 5 eyes (15%), and in none of the eyes, respectively. …”
    Get full text
    Article
  18. 818

    Short-Term Results of Switch from Conbercept to Bevacizumab or Ranibizumab in Eyes with Persistent Neovascular Age-Related Macular Degeneration by Zongyi Wang, Mengyang Li, Yuou Yao, Jie Hu, Jiyang Tang, Ran Tang, Zhenyu Piao, Jinfeng Qu

    Published 2020-01-01
    “…The average number of injections of conbercept was 3.6 ± 0.8 (range, 3–5) before switching. 18 eyes were switched to bevacizumab, and the other 46 eyes were switched to ranibizumab. …”
    Get full text
    Article
  19. 819

    Extrusion of Femtosecond Laser-Implanted Intrastromal Corneal Ring Segments in Keratoconic Eyes: Prevalence, Risk Factors, and Clinical Outcomes by Amr Mounir, Mahmoud Mohamed Farouk, Marwa Mahmoud Abdellah, Engy Mohamed Mostafa

    Published 2020-01-01
    “…To evaluate the prevalence, possible risk factors, and clinical results of femtosecond laser implanted intrastromal corneal ring segment (ICRS) extrusion in keratoconic eyes. Patients and Methods. This is a retrospective observational study evaluating 333 eyes of 269 patients who were subjected to femtosecond laser-implanted Keraring ICRS in the Sohag Refractive Center, Sohag, Egypt, from January 2014 to January 2019. …”
    Get full text
    Article
  20. 820

    Willingness to donate eyes and associated factors among adults in Addis Ababa City, Ethiopia: a mixed-methods approach by Ejigu Gebeye Zeleke, Merkineh Markos Lorato, Wubalem Addis Tefera, Hirut Gebremeskel Mengistu

    Published 2025-01-01
    “…Qualitative analysis indentified barriers such as lack of information, poor attitudes and religious restrictions.Overall, willingness to donate eyes was moderate compared to previous studies. The findings emphasise the need for community education to improve public attitudes and awareness about eye donation to enhance willingness to donate eyes.…”
    Get full text
    Article